World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
119
Citations
74865
World Ranking
3820
National Ranking
376

Overview

Martin Gore was affiliated with the Royal Marsden NHS Foundation Trust in the United Kingdom. Their research mainly focused on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a particular emphasis on Oncology, Molecular Biology, Immunology, Hematology, and Epidemiology.

Their work covered multiple key topics, including:

  • Cutaneous Melanoma Detection and Management
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Chronic Myeloid Leukemia Treatments
  • RNA modifications and cancer
  • Ovarian cancer diagnosis and treatment
  • Cancer-related molecular mechanisms research

Martin Gore contributed to several publication venues with repeated works appearing in the following:

  • European Journal of Cancer
  • UNC Libraries
  • Journal of Hepatology
  • The Lancet Gastroenterology & Hepatology
  • Journal for ImmunoTherapy of Cancer

Frequent collaborators included Henry Smith, Jessica Glen, Karen Nugent, Howard Peach, and Myles Smith, each co-authoring on multiple occasions.

Highlighted recent papers authored or co-authored by Martin Gore are:

  • Carboplatin dosage: prospective evaluation of a simple formula based on renal function, 2023, Journal of Clinical Oncology
  • Ano-uro-genital mucosal melanoma UK national guidelines, 2020, European Journal of Cancer
  • British Society of Gastroenterology endorsed guidance for the management of immune checkpoint inhibitor-induced enterocolitis, 2020, The Lancet Gastroenterology & Hepatology
  • Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis, 2021, Journal of Hepatology
  • Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma, 2020, Journal for ImmunoTherapy of Cancer

Best Publications

  • Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

    Marco Gerlinger;Andrew J. Rowan;Stuart Horswell;James Larkin

  • Sorafenib in advanced clear-cell renal-cell carcinoma.

    Bernard Escudier;Tim Eisen;Walter M. Stadler;Cezary Szczylik

  • Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

    A H Calvert;D R Newell;L A Gumbrell;S O'Reilly

  • Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial

    Brian I. Rini;Bernard Escudier;Piotr Tomczak;Andrey Kaprin

  • Recurrent Epithelial Ovarian Carcinoma: A Randomized Phase III Study of Pegylated Liposomal Doxorubicin Versus Topotecan

    Alan N. Gordon;John T. Fleagle;David Guthrie;David E. Parkin

  • A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer

    Fadlo R. Khuri;John Nemunaitis;Ian Ganly;James Arseneau

  • Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

    Bernard Escudier;Tim Eisen;Walter M. Stadler;Cezary Szczylik

  • Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing

    Marco Gerlinger;Stuart Horswell;James Larkin;Andrew J Rowan

  • Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma

    Mark J. Ratain;Tim Eisen;Walter M. Stadler;Keith T. Flaherty

  • Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

    David F. McDermott;Mahrukh A. Huseni;Michael B. Atkins;Robert J. Motzer

  • Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

    Samra Turajlic;Samra Turajlic;Kevin Litchfield;Hang Xu;Rachel Rosenthal

  • Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

    W ten Bokkel Huinink;M Gore;J Carmichael;A Gordon

  • Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial

    Robert J Motzer;Bernard Escudier;Piotr Tomczak;Thomas E Hutson

  • Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis

    T Eisen;T Ahmad;K T Flaherty;M Gore

  • Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma

    Ignace Vergote;Jos De Brabanter;Anthony Fyles;Kamma Bertelsen

  • Bcl-2 Antisense (oblimersen sodium) Plus Dacarbazine in Patients With Advanced Melanoma: The Oblimersen Melanoma Study Group

    Agop Y. Bedikian;Michael Millward;Hubert Pehamberger;Robert Conry

  • Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial.

    Alexander M. M. Eggermont;Stefan Suciu;Mario Santinami;Alessandro Testori

  • Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

    Samra Turajlic;Samra Turajlic;Hang Xu;Kevin Litchfield;Andrew Rowan

  • Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial

    Martin E Gore;Cezary Szczylik;Camillo Porta;Sergio Bracarda

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

    Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki

Frequent Co-Authors

James Larkin
James Larkin Royal Marsden NHS Foundation Trust
Stan B. Kaye
Stan B. Kaye Royal Marsden NHS Foundation Trust
Samra Turajlic
Samra Turajlic Royal Marsden NHS Foundation Trust
Bernard Escudier
Bernard Escudier Institut Gustave Roussy
Charles Swanton
Charles Swanton The Francis Crick Institute
Roger A'Hern
Roger A'Hern Royal Marsden NHS Foundation Trust
Graham G. Giles
Graham G. Giles University of Melbourne
Susan J. Ramus
Susan J. Ramus University of New South Wales
Ian G. Campbell
Ian G. Campbell Peter MacCallum Cancer Centre
Paul D.P. Pharoah
Paul D.P. Pharoah University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine doesn’t always mean medical school. There are many related online degrees and career pathways to explore in the health and medical fields. For example, if you're interested in food science and public health, an online BS in nutrition can lead to roles in dietetics, wellness coaching, or health education.

For those interested in healthcare administration, accredited MHA programs provide flexible learning for managing healthcare organizations—a vital, growing segment of the health sector.

Registered Nurses looking to advance might consider an RN to BSN online with no clinicals program. These options allow nurses to update credentials fully online, opening up new opportunities in patient care and leadership.

Finally, for those pursuing the highest level in nursing practice, finding the fastest DNP online program can help accelerate your path to becoming a clinical leader, educator, or advanced practitioner.

These alternative online degrees offer flexible routes into health careers, allowing students to specialize, advance, or pivot their professional journey in medicine and healthcare without the traditional path of medical school.

Best Scientists Citing Martin Gore